{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:41:24Z","timestamp":1791312084391,"version":"4.3.1"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1790"],"award-info":[{"award-number":["2024NSFSC1790"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M732436"],"award-info":[{"award-number":["2023M732436"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82502427"],"award-info":[{"award-number":["82502427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 project for disciplines of excellence\uff0cWest China Hospital, Sichuan University","award":["ZYGD22004"],"award-info":[{"award-number":["ZYGD22004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05373-1","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T04:57:30Z","timestamp":1775969850000},"page":"5186-5201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MR-based techniques for imaging prostate cancer metabolism: current status and future perspectives"],"prefix":"10.1007","volume":"51","author":[{"given":"Xueqing","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"issue":"3","key":"5373_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"HA-O Sung","year":"2021","unstructured":"Sung HA-O, Ferlay J, Siegel RA-O, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. doi: https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"5373_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41571-024-00891-1","volume":"21","author":"E Hoffmann","year":"2024","unstructured":"Hoffmann E, Masthoff M, Kunz WG, Seidensticker M, Bobe S, Gerwing M, et al. Multiparametric MRI for characterization of the tumour microenvironment. Nat Rev Clin Oncol. 2024;21(6):428\u201348. doi: https:\/\/doi.org\/10.1038\/s41571-024-00891-1.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"5373_CR3","first-page":"106","volume":"10","author":"M Radzina","year":"2020","unstructured":"Radzina M, Tirane M, Roznere L, Zemniece L, Dronka L, Kalnina M, et al. Accuracy of (68)Ga-PSMA-11 PET\/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer. Am J Nucl Med Mol Imaging. 2020;10(2):106\u201318.","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"3","key":"5373_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1148\/rg.2020190121","volume":"40","author":"T Tanaka","year":"2020","unstructured":"Tanaka T, Yang M, Froemming AT, Bryce AH, Inai R, Kanazawa S, et al. Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review. Radiographics. 2020;40(3):709\u201326. doi: https:\/\/doi.org\/10.1148\/rg.2020190121.","journal-title":"Radiographics"},{"issue":"1","key":"5373_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/rg.2018170108","volume":"38","author":"MS Hofman","year":"2018","unstructured":"Hofman MS, Hicks RJ, Maurer T, Eiber M. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls. Radiographics. 2018;38(1):200\u201317. doi: https:\/\/doi.org\/10.1148\/rg.2018170108.","journal-title":"Radiographics"},{"key":"5373_CR6","doi-asserted-by":"crossref","unstructured":"Epstein JI, Egevad L Fau - Amin MB, Amin Mb Fau - Delahunt B, Delahunt B Fau - Srigley JR, Srigley Jr Fau - Humphrey PA, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016;40(2):244\u2009\u2212\u200952","DOI":"10.1097\/PAS.0000000000000530"},{"key":"5373_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-025-01152-w","author":"N Vladimirov","year":"2025","unstructured":"Vladimirov N, Cohen O, Heo HY, Zaiss M, Farrar CT, Perlman O. Quantitative molecular imaging using deep magnetic resonance fingerprinting. Nat Protoc. 2025. doi: https:\/\/doi.org\/10.1038\/s41596-025-01152-w.","journal-title":"Nat Protoc"},{"issue":"2","key":"5373_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/jmri.28333","volume":"57","author":"X Cheng","year":"2023","unstructured":"Cheng X, Chen Y, Xu H, Ye L, Tong S, Li H, et al. Avoiding Unnecessary Systematic Biopsy in Clinically Significant Prostate Cancer: Comparison Between MRI-Based Radiomics Model and PI-RADS Category. J Magn Reson Imaging. 2023;57(2):578\u201386. doi: https:\/\/doi.org\/10.1002\/jmri.28333.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"5373_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13244-023-01544-0","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng X, Chen Y, Xu J, Cai D, Liu Z, Zeng H, et al. Development and validation of a predictive model based on clinical and MpMRI findings to reduce additional systematic prostate biopsy. Insights Imaging. 2024;15(1):3. doi: https:\/\/doi.org\/10.1186\/s13244-023-01544-0.","journal-title":"Insights Imaging"},{"issue":"5","key":"5373_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/liv.15222","volume":"42","author":"Z Ye","year":"2022","unstructured":"Ye Z, Song B, Lee PM, Ohliger MA, Laustsen C. Hyperpolarized carbon 13 MRI in liver diseases: Recent advances and future opportunities. Liver Int. 2022;42(5):973\u201383. doi: https:\/\/doi.org\/10.1111\/liv.15222.","journal-title":"Liver Int"},{"issue":"2","key":"5373_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00330-024-11004-y","volume":"35","author":"RA Essed","year":"2025","unstructured":"Essed RA, Prysiazhniuk Y, Wamelink IJ, Azizova A, Keil VC. Performance of amide proton transfer imaging to differentiate true progression from therapy-related changes in gliomas and metastases. Eur Radiol. 2025;35(2):580\u201391. doi: https:\/\/doi.org\/10.1007\/s00330-024-11004-y.","journal-title":"Eur Radiol"},{"issue":"2","key":"5373_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/bioengineering12020158","volume":"12","author":"T Smith","year":"2025","unstructured":"Smith T, Chau M, Sims J, Arruzza E (2025) 23Na-MRI for Breast Cancer Diagnosis and Treatment Monitoring: A Scoping Review. Bioengineering (Basel) 12(2):158. https:\/\/doi.org\/10.3390\/bioengineering12020158","journal-title":"Bioengineering (Basel)"},{"issue":"1","key":"5373_CR13","doi-asserted-by":"publisher","first-page":"tzae019","DOI":"10.1093\/bjro\/tzae019","volume":"6","author":"AGV Bitencourt","year":"2024","unstructured":"Bitencourt AGV, Bhowmik A, Marcal Filho EFL, Lo Gullo R, Mazaheri Y, Kapetas P, et al. Deuterium MR spectroscopy: potential applications in oncology research. BJR Open. 2024;6(1):tzae019. doi: https:\/\/doi.org\/10.1093\/bjro\/tzae019.","journal-title":"BJR Open"},{"issue":"4","key":"5373_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000012183","volume":"59","author":"LC Costello","year":"2000","unstructured":"Costello LC, Franklin RB. The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology. 2000;59(4):269\u201382. doi: https:\/\/doi.org\/10.1159\/000012183.","journal-title":"Oncology"},{"key":"5373_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-4598-5-17","volume":"5","author":"LC Costello","year":"2006","unstructured":"Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 2006;5:17. doi: https:\/\/doi.org\/10.1186\/1476-4598-5-17.","journal-title":"Mol Cancer"},{"key":"5373_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1476-4598-5-14","volume":"5","author":"KK Singh","year":"2006","unstructured":"Singh KK, Desouki MM, Franklin RB, Costello LC. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol Cancer. 2006;5:14. doi: https:\/\/doi.org\/10.1186\/1476-4598-5-14.","journal-title":"Mol Cancer"},{"key":"5373_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.semcancer.2020.12.002","volume":"82","author":"C Peitzsch","year":"2022","unstructured":"Peitzsch C, Gorodetska I, Klusa D, Shi Q, Alves TC, Pantel K, et al. Metabolic regulation of prostate cancer heterogeneity and plasticity. Semin Cancer Biol. 2022;82:94\u2013119. doi: https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.002.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"5373_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","volume":"21","author":"AJ Hoy","year":"2021","unstructured":"Hoy AJ, Nagarajan SR, Butler LM. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer. 2021;21(12):753\u201366. doi: https:\/\/doi.org\/10.1038\/s41568-021-00388-4.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"5373_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/metabo11110765","volume":"11","author":"H Xu","year":"2021","unstructured":"Xu H, Chen Y, Gu M, Liu C, Chen Q, Zhan M et al (2021) Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer. Metabolites 11(11):765. https:\/\/doi.org\/10.3390\/metabo11110765","journal-title":"Metabolites"},{"issue":"6","key":"5373_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.coph.2012.07.006","volume":"12","author":"K Pelton","year":"2012","unstructured":"Pelton K, Freeman MR, Solomon KR. Cholesterol and prostate cancer. Curr Opin Pharmacol. 2012;12(6):751\u20139. doi: https:\/\/doi.org\/10.1016\/j.coph.2012.07.006.","journal-title":"Curr Opin Pharmacol"},{"issue":"17","key":"5373_CR21","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.3390\/cancers14174293","volume":"14","author":"A Siltari","year":"2022","unstructured":"Siltari A, Syvala H, Lou YR, Gao Y, Murtola TJ (2022) Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor\u2019s Immune Environment. Cancers (Basel) 14(17):4293. https:\/\/doi.org\/10.3390\/cancers14174293","journal-title":"Cancers (Basel)"},{"issue":"2","key":"5373_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/aja2022105","volume":"25","author":"B Zhao","year":"2023","unstructured":"Zhao B, Wang J, Chen L, Wang H, Liang CZ, Huang J, et al. The role of glutamine metabolism in castration-resistant prostate cancer. Asian J Androl. 2023;25(2):192\u20137. doi: https:\/\/doi.org\/10.4103\/aja2022105.","journal-title":"Asian J Androl"},{"issue":"1","key":"5373_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bbrc.2014.11.105","volume":"456","author":"T Pan","year":"2015","unstructured":"Pan T, Gao L, Wu G, Shen G, Xie S, Wen H, et al. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer. Biochemical and Biophysical Research Communications. 2015;456(1):452\u20138. doi: https:\/\/doi.org\/10.1016\/j.bbrc.2014.11.105.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"5373_CR24","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1021\/acsnano.4c16981","volume":"19","author":"X Cheng","year":"2025","unstructured":"Cheng X, Xu J, Cui Y, Liu J, Chen Y, He C, et al. Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity. ACS Nano. 2025;19(7):7213\u201330. doi: https:\/\/doi.org\/10.1021\/acsnano.4c16981.","journal-title":"ACS Nano"},{"issue":"4","key":"5373_CR25","doi-asserted-by":"publisher","first-page":"e050264","DOI":"10.1136\/bmjopen-2021-050264","volume":"12","author":"A Siltari","year":"2022","unstructured":"Siltari A, Riikonen J, Koskim\u00e4ki J, Pakarainen T, Ettala O, Bostr\u00f6m P, et al. Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol. BMJ Open. 2022;12(4):e050264. doi: https:\/\/doi.org\/10.1136\/bmjopen-2021-050264.","journal-title":"BMJ Open"},{"issue":"3","key":"5373_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ejrad.2010.04.028","volume":"81","author":"K Pinker","year":"2012","unstructured":"Pinker K, Stadlbauer A, Bogner W, Gruber S, Helbich TH. Molecular imaging of cancer: MR spectroscopy and beyond. European Journal of Radiology. 2012;81(3):566\u201377. doi: https:\/\/doi.org\/10.1016\/j.ejrad.2010.04.028.","journal-title":"European Journal of Radiology"},{"issue":"3","key":"5373_CR27","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/0022-2364(90)90319-5","volume":"87","author":"MA Thomas","year":"1969","unstructured":"Thomas MA, Narayan P, Kurhanewicz J, Jajodia P, Weiner MW (1969) 1H MR spectroscopy of normal and malignant human prostates in Vivo. Journal of Magnetic Resonance (1969) 87(3):610\u2013619. https:\/\/doi.org\/10.1016\/0022-2364(90)90319-5","journal-title":"Journal of Magnetic Resonance (1969)"},{"key":"5373_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ab.2017.02.001","volume":"529","author":"N Tayari","year":"2017","unstructured":"Tayari N, Heerschap A, Scheenen TWJ, Kobus T. In vivo MR spectroscopic imaging of the prostate, from application to interpretation. Anal Biochem. 2017;529:158\u201370. doi: https:\/\/doi.org\/10.1016\/j.ab.2017.02.001.","journal-title":"Anal Biochem"},{"issue":"1","key":"5373_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12929-021-00750-6","volume":"28","author":"N Gholizadeh","year":"2021","unstructured":"Gholizadeh N, Greer PB, Simpson J, Goodwin J, Fu C, Lau P, et al. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection. J Biomed Sci. 2021;28(1):54. doi: https:\/\/doi.org\/10.1186\/s12929-021-00750-6.","journal-title":"J Biomed Sci"},{"issue":"3","key":"5373_CR30","doi-asserted-by":"publisher","first-page":"e5062","DOI":"10.1002\/nbm.5062","volume":"37","author":"A Stamatelatou","year":"2024","unstructured":"Stamatelatou A, Bertinetto CG, Jansen JJ, Postma G, Selnaes KM, Bathen TF, et al. A multivariate curve resolution analysis of multicenter proton spectroscopic imaging of the prostate for cancer localization and assessment of aggressiveness. NMR Biomed. 2024;37(3):e5062. doi: https:\/\/doi.org\/10.1002\/nbm.5062.","journal-title":"NMR Biomed"},{"issue":"5","key":"5373_CR31","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/mrm.29565","volume":"89","author":"A Stamatelatou","year":"2023","unstructured":"Stamatelatou A, Sima DM, van Huffel S, van Asten JJA, Heerschap A, Scheenen TWJ. Post-acquisition water-signal removal in 3D water-unsuppressed (1) H-MR spectroscopic imaging of the prostate. Magn Reson Med. 2023;89(5):1741\u201353. doi: https:\/\/doi.org\/10.1002\/mrm.29565.","journal-title":"Magn Reson Med"},{"issue":"3","key":"5373_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/(sici)1097-0045(19990215)38:3<237::aid-pros8>3.0.co;2-o","volume":"38","author":"LC Costello","year":"1999","unstructured":"Costello LC, Franklin RB, Narayan P. Citrate in the diagnosis of prostate cancer. Prostate. 1999;38(3):237\u201345. doi: https:\/\/doi.org\/10.1002\/(sici)1097-0045(19990215)38:3%3C237::aid-pros8%3E3.0.co;2-o.","journal-title":"Prostate"},{"key":"5373_CR33","unstructured":"Pretlow Tg 2nd Fau - Whitehurst GB, Whitehurst Gb Fau - Pretlow TP, Pretlow Tp Fau - Hunt RS, Hunt Rs Fau - Jacobs JM, Jacobs Jm Fau - McKenzie DR, McKenzie Dr Fau - McDaniel HG, et al. Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia. Cancer Res. 1982;42(11):4842-8."},{"issue":"6","key":"5373_CR34","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/mrm.20909","volume":"55","author":"MG Swanson","year":"2006","unstructured":"Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, et al. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med. 2006;55(6):1257\u201364. doi: https:\/\/doi.org\/10.1002\/mrm.20909.","journal-title":"Magn Reson Med"},{"issue":"6","key":"5373_CR35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/jmri.26803","volume":"50","author":"N Gholizadeh","year":"2019","unstructured":"Gholizadeh N, Greer PB, Simpson J, Fu C, Al-Iedani O, Lau P, et al. Supervised risk predictor of central gland lesions in prostate cancer using (1) H MR spectroscopic imaging with gradient offset-independent adiabaticity pulses. J Magn Reson Imaging. 2019;50(6):1926\u201336. doi: https:\/\/doi.org\/10.1002\/jmri.26803.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"5373_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1148\/radiology.213.2.r99nv23473","volume":"213","author":"J Scheidler","year":"1999","unstructured":"Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate Cancer: Localization with Three-dimensional Proton MR Spectroscopic Imaging\u2014Clinicopathologic Study. Radiology. 1999;213(2):473\u201380. doi: https:\/\/doi.org\/10.1148\/radiology.213.2.r99nv23473.","journal-title":"Radiology"},{"issue":"3","key":"5373_CR37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1148\/radiol.2333030672","volume":"233","author":"JA Jung","year":"2004","unstructured":"Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, et al. Prostate Depiction at Endorectal MR Spectroscopic Imaging: Investigation of a Standardized Evaluation System. Radiology. 2004;233(3):701\u20138. doi: https:\/\/doi.org\/10.1148\/radiol.2333030672.","journal-title":"Radiology"},{"issue":"2","key":"5373_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1148\/radiol.2412051866","volume":"241","author":"JJ F\u00fctterer","year":"2006","unstructured":"F\u00fctterer JJ, Heijmink SWTPJ, Scheenen TWJ, Veltman J, Huisman HJ, Vos P, et al. Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging. Radiology. 2006;241(2):449\u201358. doi: https:\/\/doi.org\/10.1148\/radiol.2412051866.","journal-title":"Radiology"},{"issue":"1","key":"5373_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/RLI.0b013e3181f54081","volume":"46","author":"TWJ Scheenen","year":"2011","unstructured":"Scheenen TWJ, F\u00fctterer J, Weiland E, Van Hecke P, Lemort M, Zechmann C, et al. Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: A prospective multicenter validation study. Investigative Radiology. 2011;46(1):25\u201333. doi: https:\/\/doi.org\/10.1097\/RLI.0b013e3181f54081.","journal-title":"Investigative Radiology"},{"issue":"5","key":"5373_CR40","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.eururo.2011.03.002","volume":"60","author":"T Kobus","year":"2011","unstructured":"Kobus T, Hambrock T, Hulsbergen-Van de Kaa CA, Wright AJ, Barentsz JO, Heerschap A, Scheenen TW (2011) In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. Eur Urol 60(5):1074\u20131080","journal-title":"Eur Urol"},{"issue":"2","key":"5373_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1148\/radiol.12111744","volume":"265","author":"T Kobus","year":"2012","unstructured":"Kobus T, Vos PC, Hambrock T, De Rooij M, Hulsbergen\u2014Van de Kaa CA, Barentsz JO, et al. Prostate Cancer Aggressiveness: In Vivo Assessment of MR Spectroscopy and Diffusion-weighted Imaging at 3 T. Radiology. 2012;265(2):457\u201367. doi: https:\/\/doi.org\/10.1148\/radiol.12111744.","journal-title":"Radiology"},{"issue":"8","key":"5373_CR42","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.21037\/qims-21-331","volume":"11","author":"M Deal","year":"2021","unstructured":"Deal M, Bardet F, Walker PM, de la Vega MF, Cochet A, Cormier L, et al. Three-dimensional nuclear magnetic resonance spectroscopy: a complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0T. Quant Imaging Med Surg. 2021;11(8):3749\u201366. doi: https:\/\/doi.org\/10.21037\/qims-21-331.","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"5373_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jmir.2017.06.004","volume":"48","author":"R Faghihi","year":"2017","unstructured":"Faghihi R, Zeinali-Rafsanjani B, Mosleh-Shirazi MA, Saeedi-Moghadam M, Lotfi M, Jalli R, et al. Magnetic Resonance Spectroscopy and its Clinical Applications: A Review. J Med Imaging Radiat Sci. 2017;48(3):233\u201353. doi: https:\/\/doi.org\/10.1016\/j.jmir.2017.06.004.","journal-title":"J Med Imaging Radiat Sci"},{"issue":"2","key":"5373_CR44","first-page":"104","volume":"23","author":"M Zabihzadeh","year":"2020","unstructured":"Zabihzadeh M, Fatahi Asl J, Farzanegan Z, Hoseini SM, Sarkarian M, Cheraghian B, et al. Accuracy of Magnetic Resonance Spectroscopy Techniques in Prostate Cancer and Prostatitis. Arch Iran Med. 2020;23(2):104\u201312.","journal-title":"Arch Iran Med"},{"issue":"30","key":"5373_CR45","doi-asserted-by":"publisher","first-page":"11795","DOI":"10.1021\/ja2045925","volume":"133","author":"SE Bohndiek","year":"2011","unstructured":"Bohndiek SE, Kettunen MI, Hu D-e, Kennedy BWC, Boren J, Gallagher FA, et al. Hyperpolarized [1-13\u00a0C]-Ascorbic and Dehydroascorbic Acid: Vitamin C as a Probe for Imaging Redox Status in Vivo. Journal of the American Chemical Society. 2011;133(30):11795\u2013801. doi: https:\/\/doi.org\/10.1021\/ja2045925.","journal-title":"Journal of the American Chemical Society"},{"issue":"6","key":"5373_CR46","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2967\/jnumed.112.115402","volume":"54","author":"KR Keshari","year":"2013","unstructured":"Keshari KR, Sai V, Wang ZJ, Vanbrocklin HF, Kurhanewicz J, Wilson DM. Hyperpolarized [1-13\u00a0C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET. J Nucl Med. 2013;54(6):922\u20138. doi: https:\/\/doi.org\/10.2967\/jnumed.112.115402.","journal-title":"J Nucl Med"},{"issue":"6","key":"5373_CR47","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/mrm.25360","volume":"73","author":"C Canape","year":"2015","unstructured":"Canape C, Catanzaro G, Terreno E, Karlsson M, Lerche MH, Jensen PR. Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5-(13) C]glutamine. Magn Reson Med. 2015;73(6):2296\u2013305. doi: https:\/\/doi.org\/10.1002\/mrm.25360.","journal-title":"Magn Reson Med"},{"issue":"1","key":"5373_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3978\/j.issn.2223-4292.2014.02.02","volume":"4","author":"N Bahrami","year":"2014","unstructured":"Bahrami N, Swisher CL, Von Morze C, Vigneron DB, Larson PE. Kinetic and perfusion modeling of hyperpolarized (13)C pyruvate and urea in cancer with arbitrary RF flip angles. Quant Imaging Med Surg. 2014;4(1):24\u201332. doi: https:\/\/doi.org\/10.3978\/j.issn.2223-4292.2014.02.02.","journal-title":"Quant Imaging Med Surg"},{"issue":"7","key":"5373_CR49","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/mp.14179","volume":"47","author":"CJ Harlan","year":"2020","unstructured":"Harlan CJ, Xu Z, Michel KA, Walker CM, Lokugama SD, Martinez GV, et al. Technical Note: A deuterated (13) C-urea reference for clinical multiparametric MRI prostate cancer studies including hyperpolarized pyruvate. Med Phys. 2020;47(7):2931\u20136. doi: https:\/\/doi.org\/10.1002\/mp.14179.","journal-title":"Med Phys"},{"issue":"58","key":"5373_CR50","doi-asserted-by":"publisher","first-page":"6096","DOI":"10.18632\/oncotarget.27225","volume":"10","author":"DE Korenchan","year":"2019","unstructured":"Korenchan DE, Bok R, Sriram R, Liu K, Santos RD, Qin H, et al. Hyperpolarized in vivo pH imaging reveals grade-dependent acidification in prostate cancer. Oncotarget. 2019;10(58):6096\u2013110. doi: https:\/\/doi.org\/10.18632\/oncotarget.27225.","journal-title":"Oncotarget"},{"issue":"14","key":"5373_CR51","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1039\/c5cc09724j","volume":"52","author":"DE Korenchan","year":"2016","unstructured":"Korenchan DE, Flavell RR, Baligand C, Sriram R, Neumann K, Sukumar S, et al. Dynamic nuclear polarization of biocompatible (13)C-enriched carbonates for in vivo pH imaging. Chem Commun (Camb). 2016;52(14):3030\u20133. doi: https:\/\/doi.org\/10.1039\/c5cc09724j.","journal-title":"Chem Commun (Camb)"},{"issue":"5","key":"5373_CR52","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3348\/kjr.2024.0069","volume":"25","author":"YC Lai","year":"2024","unstructured":"Lai YC, Hsieh CY, Juan YH, Lu KY, Lee HJ, Ng SH, et al. Hyperpolarized Carbon-13 Magnetic Resonance Imaging: Technical Considerations and Clinical Applications. Korean J Radiol. 2024;25(5):459\u201372. doi: https:\/\/doi.org\/10.3348\/kjr.2024.0069.","journal-title":"Korean J Radiol"},{"issue":"20","key":"5373_CR53","doi-asserted-by":"publisher","first-page":"8607","DOI":"10.1158\/0008-5472.CAN-08-0749","volume":"68","author":"MJ Albers","year":"2008","unstructured":"Albers MJ, Bok R, Chen AP, Cunningham CH, Zierhut ML, Zhang VY, et al. Hyperpolarized 13\u00a0C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res. 2008;68(20):8607\u201315. doi: https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0749.","journal-title":"Cancer Res"},{"issue":"11","key":"5373_CR54","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/pros.22665","volume":"73","author":"KR Keshari","year":"2013","unstructured":"Keshari KR, Sriram R, Van Criekinge M, Wilson DM, Wang ZJ, Vigneron DB, et al. Metabolic reprogramming and validation of hyperpolarized 13\u00a0C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. Prostate. 2013;73(11):1171\u201381. doi: https:\/\/doi.org\/10.1002\/pros.22665.","journal-title":"Prostate"},{"issue":"198","key":"5373_CR55","doi-asserted-by":"publisher","first-page":"198ra08","DOI":"10.1126\/scitranslmed.3006070","volume":"5","author":"SJ Nelson","year":"2013","unstructured":"Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PE, Harzstark AL, Ferrone M, et al. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-(1)(3)C]pyruvate. Sci Transl Med. 2013;5(198):198ra08. doi: https:\/\/doi.org\/10.1126\/scitranslmed.3006070.","journal-title":"Sci Transl Med"},{"issue":"12","key":"5373_CR56","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1158\/0008-5472.CAN-16-2083","volume":"77","author":"HY Chen","year":"2017","unstructured":"Chen HY, Larson PEZ, Bok RA, von Morze C, Sriram R, Delos Santos R, et al. Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion. Cancer Res. 2017;77(12):3207\u201316. doi: https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2083.","journal-title":"Cancer Res"},{"issue":"2","key":"5373_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/cancers11020257","volume":"11","author":"R Bok","year":"2019","unstructured":"Bok R, Lee J, Sriram R, Keshari K, Sukumar S, Daneshmandi S et al (2019) The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized (13)C MRSI. Cancers (Basel) 11(2):257. https:\/\/doi.org\/10.3390\/cancers11020257","journal-title":"Cancers (Basel)"},{"issue":"7","key":"5373_CR58","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.mri.2014.04.015","volume":"32","author":"KL Billingsley","year":"2014","unstructured":"Billingsley KL, Park JM, Josan S, Hurd R, Mayer D, Spielman-Sun E, et al. The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-(13)C]-ketoisocaproate. Magn Reson Imaging. 2014;32(7):791\u20135. doi: https:\/\/doi.org\/10.1016\/j.mri.2014.04.015.","journal-title":"Magn Reson Imaging"},{"issue":"4","key":"5373_CR59","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jmri.24433","volume":"40","author":"CL Mallett","year":"2014","unstructured":"Mallett CL, Lim H, Thind K, Chen Y, Ribot EJ, Martinez F, et al. Longitudinal anatomical and metabolic MRI characterization of orthotopic xenograft prostate tumors in nude mice. J Magn Reson Imaging. 2014;40(4):848\u201356. doi: https:\/\/doi.org\/10.1002\/jmri.24433.","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"5373_CR60","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.eururo.2017.07.022","volume":"72","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal R, Vigneron DB, Kurhanewicz J. Hyperpolarized 1-[(13)C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer. Eur Urol. 2017;72(6):1028\u20139. doi: https:\/\/doi.org\/10.1016\/j.eururo.2017.07.022.","journal-title":"Eur Urol"},{"issue":"13","key":"5373_CR61","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1158\/1078-0432.CCR-17-1957","volume":"24","author":"BT Scroggins","year":"2018","unstructured":"Scroggins BT, Matsuo M, White AO, Saito K, Munasinghe JP, Sourbier C, et al. Hyperpolarized [1-(13)C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer In Vivo Predicts Efficacy of Targeting the Warburg Effect. Clin Cancer Res. 2018;24(13):3137\u201348. doi: https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1957.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5373_CR62","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1158\/1541-7786.MCR-17-0458","volume":"16","author":"SS Tee","year":"2018","unstructured":"Tee SS, Suster I, Truong S, Jeong S, Eskandari R, DiGialleonardo V, et al. Targeted AKT Inhibition in Prostate Cancer Cells and Spheroids Reduces Aerobic Glycolysis and Generation of Hyperpolarized [1-(13)C] Lactate. Mol Cancer Res. 2018;16(3):453\u201360. doi: https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0458.","journal-title":"Mol Cancer Res"},{"issue":"5","key":"5373_CR63","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11307-018-1235-6","volume":"21","author":"SV Bachawal","year":"2019","unstructured":"Bachawal SV, Park JM, Valluru KS, Loft MD, Felt SA, Vilches-Moure JG, et al. Multimodality Hyperpolarized C-13 MRS\/PET\/Multiparametric MR Imaging for Detection and Image-Guided Biopsy of Prostate Cancer: First Experience in a Canine Prostate Cancer Model. Mol Imaging Biol. 2019;21(5):861\u201370. doi: https:\/\/doi.org\/10.1007\/s11307-018-1235-6.","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"5373_CR64","doi-asserted-by":"publisher","first-page":"e3962","DOI":"10.1002\/nbm.3962","volume":"32","author":"JE Lee","year":"2019","unstructured":"Lee JE, Diederich CJ, Bok R, Sriram R, Santos RD, Noworolski SM, et al. Assessing high-intensity focused ultrasound treatment of prostate cancer with hyperpolarized (13) C dual-agent imaging of metabolism and perfusion. NMR Biomed. 2019;32(10):e3962. doi: https:\/\/doi.org\/10.1002\/nbm.3962.","journal-title":"NMR Biomed"},{"issue":"1","key":"5373_CR65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11307-018-1199-6","volume":"21","author":"N Zacharias","year":"2019","unstructured":"Zacharias N, Lee J, Ramachandran S, Shanmugavelandy S, McHenry J, Dutta P, et al. Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo. Mol Imaging Biol. 2019;21(1):86\u201394. doi: https:\/\/doi.org\/10.1007\/s11307-018-1199-6.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"5373_CR66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41391-019-0180-z","volume":"23","author":"HY Chen","year":"2020","unstructured":"Chen HY, Aggarwal R, Bok RA, Ohliger MA, Zhu Z, Lee P, et al. Hyperpolarized (13)C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study. Prostate Cancer Prostatic Dis. 2020;23(2):269\u201376. doi: https:\/\/doi.org\/10.1038\/s41391-019-0180-z.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"5373_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cmet.2019.08.024","volume":"31","author":"KL Granlund","year":"2020","unstructured":"Granlund KL, Tee SS, Vargas HA, Lyashchenko SK, Reznik E, Fine S, et al. Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1. Cell Metab. 2020;31(1):105\u2009\u2013\u200914 e3. doi: https:\/\/doi.org\/10.1016\/j.cmet.2019.08.024.","journal-title":"Cell Metab"},{"issue":"3","key":"5373_CR68","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/cancers12030537","volume":"12","author":"R Sriram","year":"2020","unstructured":"Sriram R, Van Criekinge M, DeLos Santos J, Ahamed F, Qin H, Nolley R et al (2020) Elevated Tumor Lactate and Efflux in High-grade Prostate Cancer demonstrated by Hyperpolarized (13)C Magnetic Resonance Spectroscopy of Prostate Tissue Slice Cultures. Cancers (Basel) 12(3):537. https:\/\/doi.org\/10.3390\/cancers12030537","journal-title":"Cancers (Basel)"},{"issue":"5","key":"5373_CR69","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ijrobp.2020.04.022","volume":"107","author":"H Qin","year":"2020","unstructured":"Qin H, Zhang V, Bok RA, Santos RD, Cunha JA, Hsu IC, et al. Simultaneous Metabolic and Perfusion Imaging Using Hyperpolarized (13)C MRI Can Evaluate Early and Dose-Dependent Response to Radiation Therapy in a Prostate Cancer Mouse Model. Int J Radiat Oncol Biol Phys. 2020;107(5):887\u201396. doi: https:\/\/doi.org\/10.1016\/j.ijrobp.2020.04.022.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"5373_CR70","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/mrm.29399","volume":"88","author":"HY Chen","year":"2022","unstructured":"Chen HY, Bok RA, Cooperberg MR, Nguyen HG, Shinohara K, Westphalen AC, et al. Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized (13) C pyruvate metabolic imaging: A technical development study. Magn Reson Med. 2022;88(6):2609\u201320. doi: https:\/\/doi.org\/10.1002\/mrm.29399.","journal-title":"Magn Reson Med"},{"issue":"2","key":"5373_CR71","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.eururo.2021.10.015","volume":"81","author":"I de Kouchkovsky","year":"2022","unstructured":"de Kouchkovsky I, Chen HY, Ohliger MA, Wang ZJ, Bok RA, Gordon JW, et al. Hyperpolarized 1-[(13)C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer. Eur Urol. 2022;81(2):219\u201321. doi: https:\/\/doi.org\/10.1016\/j.eururo.2021.10.015.","journal-title":"Eur Urol"},{"issue":"1","key":"5373_CR72","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41467-022-28069-2","volume":"13","author":"N Sushentsev","year":"2022","unstructured":"Sushentsev N, McLean MA, Warren AY, Benjamin AJV, Brodie C, Frary A, et al. Hyperpolarised (13)C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer. Nat Commun. 2022;13(1):466. doi: https:\/\/doi.org\/10.1038\/s41467-022-28069-2.","journal-title":"Nat Commun"},{"issue":"6","key":"5373_CR73","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/jmri.28467","volume":"57","author":"R Chowdhury","year":"2023","unstructured":"Chowdhury R, Mueller CA, Smith L, Gong F, Papoutsaki MV, Rogers H, et al. Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-(13) C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade. J Magn Reson Imaging. 2023;57(6):1865\u201375. doi: https:\/\/doi.org\/10.1002\/jmri.28467.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"5373_CR74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.mri.2009.07.007","volume":"28","author":"JM Lupo","year":"2010","unstructured":"Lupo JM, Chen AP, Zierhut ML, Bok RA, Cunningham CH, Kurhanewicz J, et al. Analysis of hyperpolarized dynamic 13\u00a0C lactate imaging in a transgenic mouse model of prostate cancer. Magn Reson Imaging. 2010;28(2):153\u201362. doi: https:\/\/doi.org\/10.1016\/j.mri.2009.07.007.","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"5373_CR75","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/cancers12030537","volume":"12","author":"R Sriram","year":"2020","unstructured":"Sriram R, Van Criekinge M, DeLos Santos J, Ahamed F, Qin H, Nolley R, et al. Elevated Tumor Lactate and Efflux in High-grade Prostate Cancer demonstrated by Hyperpolarized (13)C Magnetic Resonance Spectroscopy of Prostate Tissue Slice Cultures. LID \u2013\u200910.3390\/cancers12030537 [doi] LID \u2013\u2009537. Cancers (Basel). 2020;12(3):537.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"5373_CR76","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/path.4547","volume":"236","author":"N Pertega-Gomes","year":"2015","unstructured":"Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, et al. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. Journal of Pathology. 2015;236(4):517\u201330. doi: https:\/\/doi.org\/10.1002\/path.4547.","journal-title":"Journal of Pathology"},{"issue":"1","key":"5373_CR77","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1038\/s41467-024-50362-5","volume":"15","author":"N Sushentsev","year":"2024","unstructured":"Sushentsev N, Hamm G, Flint L, Birtles D, Zakirov A, Richings J, et al. Metabolic imaging across scales reveals distinct prostate cancer phenotypes. Nat Commun. 2024;15(1):5980. doi: https:\/\/doi.org\/10.1038\/s41467-024-50362-5.","journal-title":"Nat Commun"},{"issue":"46","key":"5373_CR78","doi-asserted-by":"publisher","first-page":"18606","DOI":"10.1073\/pnas.1106920108","volume":"108","author":"KR Keshari","year":"2011","unstructured":"Keshari KR, Kurhanewicz J, Bok R, Larson PE, Vigneron DB, Wilson DM. Hyperpolarized 13\u00a0C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging. Proc Natl Acad Sci U S A. 2011;108(46):18606\u201311. doi: https:\/\/doi.org\/10.1073\/pnas.1106920108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5373_CR79","doi-asserted-by":"publisher","first-page":"778761","DOI":"10.3389\/fonc.2021.778761","volume":"11","author":"G Fidelito","year":"2021","unstructured":"Fidelito G, Watt MJ, Taylor RA. Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality? Front Oncol. 2021;11:778761. doi: https:\/\/doi.org\/10.3389\/fonc.2021.778761.","journal-title":"Front Oncol"},{"issue":"15_suppl","key":"5373_CR80","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1200\/jco.2012.30.15_suppl.4660","volume":"30","author":"AL Harzstark","year":"2012","unstructured":"Harzstark AL, Weinberg VK, Grycz K, Hurd RE, Ardenkjaer-Larsen JH, Murray J, et al. A first-in-human phase I imaging study using hyperpolarized 1c-13 pyruvate (h-Py) in patients (pts) with localized prostate cancer (l-PCa). Journal of Clinical Oncology. 2012;30(15_suppl):4660-. doi: https:\/\/doi.org\/10.1200\/jco.2012.30.15_suppl.4660.","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"5373_CR81","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/mrm.29551","volume":"89","author":"Z Xu","year":"2023","unstructured":"Xu Z, Michel KA, Walker CM, Harlan CJ, Martinez GV, Gordon JW, et al. Model-constrained reconstruction accelerated with Fourier-based undersampling for hyperpolarized [1-(13) C] pyruvate imaging. Magn Reson Med. 2023;89(4):1481\u201395. doi: https:\/\/doi.org\/10.1002\/mrm.29551.","journal-title":"Magn Reson Med"},{"issue":"2","key":"5373_CR82","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/tomography9020059","volume":"9","author":"SI Sahin","year":"2023","unstructured":"Sahin SI, Ji X, Agarwal S, Sinha A, Mali I, Gordon JW, et al. Metabolite-Specific Echo Planar Imaging for Preclinical Studies with Hyperpolarized (13)C-Pyruvate MRI. Tomography. 2023;9(2):736\u201349. doi: https:\/\/doi.org\/10.3390\/tomography9020059.","journal-title":"Tomography"},{"key":"5373_CR83","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mri.2024.01.006","volume":"107","author":"L Sheng","year":"2024","unstructured":"Sheng L, Yuan E, Yuan F, Song B. Amide proton transfer-weighted imaging of the abdomen: Current progress and future directions. Magn Reson Imaging. 2024;107:88\u201399. doi: https:\/\/doi.org\/10.1016\/j.mri.2024.01.006.","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"5373_CR84","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jmri.22480","volume":"33","author":"G Jia","year":"2011","unstructured":"Jia G, Abaza R, Williams JD, Zynger DL, Zhou J, Shah ZK, et al. Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging. 2011;33(3):647\u201354. doi: https:\/\/doi.org\/10.1002\/jmri.22480.","journal-title":"J Magn Reson Imaging"},{"key":"5373_CR85","doi-asserted-by":"publisher","first-page":"640906","DOI":"10.3389\/fonc.2021.640906","volume":"11","author":"H Yin","year":"2021","unstructured":"Yin H, Wang D, Yan R, Jin X, Hu Y, Zhai Z, et al. Comparison of Diffusion Kurtosis Imaging and Amide Proton Transfer Imaging in the Diagnosis and Risk Assessment of Prostate Cancer. Front Oncol. 2021;11:640906. doi: https:\/\/doi.org\/10.3389\/fonc.2021.640906.","journal-title":"Front Oncol"},{"issue":"5","key":"5373_CR86","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jmri.28204","volume":"56","author":"Z Guo","year":"2022","unstructured":"Guo Z, Qin X, Mu R, Lv J, Meng Z, Zheng W, et al. Amide Proton Transfer Could Provide More Accurate Lesion Characterization in the Transition Zone of the Prostate. J Magn Reson Imaging. 2022;56(5):1311\u20139. doi: https:\/\/doi.org\/10.1002\/jmri.28204.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"5373_CR87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40644-022-00515-w","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, Wang L, Tan Y, Dan H, Xian P, Zhang Y, et al. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study. Cancer Imaging. 2023;23(1):3. doi: https:\/\/doi.org\/10.1186\/s40644-022-00515-w.","journal-title":"Cancer Imaging"},{"key":"5373_CR88","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mri.2022.11.004","volume":"96","author":"W Hu","year":"2023","unstructured":"Hu W, Chen L, Lin L, Wang J, Wang N, Liu A. Three-dimensional amide proton transfer-weighted and intravoxel incoherent motion imaging for predicting bone metastasis in patients with prostate cancer: A pilot study. Magn Reson Imaging. 2023;96:8\u201316. doi: https:\/\/doi.org\/10.1016\/j.mri.2022.11.004.","journal-title":"Magn Reson Imaging"},{"issue":"2","key":"5373_CR89","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/RCT.0000000000001398","volume":"47","author":"A Kido","year":"2023","unstructured":"Kido A, Tamada T, Ueda Y, Takeuchi M, Kanki A, Yamamoto A. Comparison Between Amide Proton Transfer Magnetic Resonance Imaging Using 3-Dimensional Acquisition and Diffusion-Weighted Imaging for Characterization of Prostate Cancer: A Preliminary Study. J Comput Assist Tomogr. 2023;47(2):178\u201385. doi: https:\/\/doi.org\/10.1097\/RCT.0000000000001398.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"5373_CR90","doi-asserted-by":"publisher","first-page":"812","DOI":"10.21037\/qims-22-721","volume":"13","author":"X Qin","year":"2023","unstructured":"Qin X, Mu R, Zheng W, Li X, Liu F, Zhuang Z, et al. Comparison and combination of amide proton transfer magnetic resonance imaging and the apparent diffusion coefficient in differentiating the grades of prostate cancer. Quant Imaging Med Surg. 2023;13(2):812\u201324. doi: https:\/\/doi.org\/10.21037\/qims-22-721.","journal-title":"Quant Imaging Med Surg"},{"issue":"12","key":"5373_CR91","doi-asserted-by":"publisher","first-page":"9036","DOI":"10.21037\/qims-24-1121","volume":"14","author":"Y Ye","year":"2024","unstructured":"Ye Y, Gong Z, Song Y, Yv L, Liu Z, Ying H, et al. Added value of amide proton transfer-weighted magnetic resonance imaging to Prostate Imaging Reporting and Data System version 2.1 in differentiating clinically significant prostate cancer. Quant Imaging Med Surg. 2024;14(12):9036\u201348. doi: https:\/\/doi.org\/10.21037\/qims-24-1121.","journal-title":"Quant Imaging Med Surg"},{"key":"5373_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-04901-3","author":"Z Gong","year":"2025","unstructured":"Gong Z, Jiang F, Liu Z, Chen Z, Peng Y, Qiu J, et al. Exploring the value of multiparametric quantitative magnetic resonance imaging in avoiding unnecessary biopsy in patients with PI-RADS 3\u20134. Abdom Radiol (NY). 2025. doi: https:\/\/doi.org\/10.1007\/s00261-025-04901-3.","journal-title":"Abdom Radiol (NY)"},{"issue":"10","key":"5373_CR93","doi-asserted-by":"publisher","first-page":"e4958","DOI":"10.1002\/nbm.4958","volume":"36","author":"DJ Reesink","year":"2023","unstructured":"Reesink DJ, Arteaga de Castro CS, Van der Velden T, Van Vooren J, Oost P, Jonges TGN, et al. Feasibility of clinical studies of chemical exchange saturation transfer magnetic resonance imaging of prostate cancer at 7 T. NMR Biomed. 2023;36(10):e4958. doi: https:\/\/doi.org\/10.1002\/nbm.4958.","journal-title":"NMR Biomed"},{"issue":"1","key":"5373_CR94","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1186\/s12885-025-14610-1","volume":"25","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li L, Zhe X, Tang M, Lei X, Zhang J, et al. Combination of PI-RADS version 2.1 and amide proton transfer values for the detection of clinically significant prostate cancer. BMC Cancer. 2025;25(1):1249. doi: https:\/\/doi.org\/10.1186\/s12885-025-14610-1.","journal-title":"BMC Cancer"},{"issue":"1","key":"5373_CR95","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00345-025-05640-2","volume":"43","author":"H Fang","year":"2025","unstructured":"Fang H, Hou W, Wang Q, Zhang X, Wang X, Zhang S, et al. Diagnosis and risk stratification of PI-RADS v2.1 category 3\u20135 lesions using amide proton transfer imaging. World J Urol. 2025;43(1):273. doi: https:\/\/doi.org\/10.1007\/s00345-025-05640-2.","journal-title":"World J Urol"},{"issue":"12","key":"5373_CR96","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41551-017-0168-8","volume":"1","author":"G Liu","year":"2017","unstructured":"Liu G, Banerjee SR, Yang X, Yadav N, Lisok A, Jablonska A, et al. A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen. Nature Biomedical Engineering. 2017;1(12):977\u201382. doi: https:\/\/doi.org\/10.1038\/s41551-017-0168-8.","journal-title":"Nature Biomedical Engineering"},{"issue":"19","key":"5373_CR97","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.3390\/cancers14194916","volume":"14","author":"P Irrera","year":"2022","unstructured":"Irrera P, Consolino L, Roberto M, Capozza M, Dhakan C, Carella A, et al. In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models. Cancers. 2022;14(19):4916.","journal-title":"Cancers"},{"issue":"1","key":"5373_CR98","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/metabo13010048","volume":"13","author":"P Irrera","year":"2023","unstructured":"Irrera P, Roberto M, Consolino L, Anemone A, Villano D, Navarro-Tableros V, et al. Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging. Metabolites. 2023;13(1):48.","journal-title":"Metabolites"},{"issue":"4","key":"5373_CR99","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/jmri.27147","volume":"53","author":"LO Poku","year":"2021","unstructured":"Poku LO, Phil M, Cheng Y, Wang K, Sun X (2021) 23) Na-MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis. J Magn Reson Imaging 53(4):995\u20131014. https:\/\/doi.org\/10.1002\/jmri.27147","journal-title":"J Magn Reson Imaging"},{"key":"5373_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnmrs.2023.04.002","volume":"138\u2013139","author":"LV Gast","year":"2023","unstructured":"Gast LV, Platt T, Nagel AM, Gerhalter T. Recent technical developments and clinical research applications of sodium ((23)Na) MRI. Prog Nucl Magn Reson Spectrosc. 2023;138\u2013139:1\u201351. doi: https:\/\/doi.org\/10.1016\/j.pnmrs.2023.04.002.","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"issue":"3","key":"5373_CR101","doi-asserted-by":"publisher","first-page":"umae023","DOI":"10.1093\/radadv\/umae023","volume":"1","author":"JL Tan","year":"2024","unstructured":"Tan JL, Kalia V, Pautler SE, Bauman G, Gast LV, M\u00fcller M, Nagel AM, Thiessen JD, Scholl TJ, Akbari A (2024) Different sodium concentrations of noncancerous and cancerous prostate tissue seen on MRI using an external coil. Radiol Adv 1(3):umae023. https:\/\/doi.org\/10.1093\/radadv\/umae023","journal-title":"Radiol Adv"},{"issue":"12","key":"5373_CR102","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/RLI.0b013e318267bc6f","volume":"47","author":"D Hausmann","year":"2012","unstructured":"Hausmann D, Konstandin S, Wetterling F, Haneder S, Nagel AM, Dinter DJ, et al. Apparent Diffusion Coefficient and Sodium Concentration Measurements in Human Prostate Tissue via Hydrogen-1 and Sodium-23 Magnetic Resonance Imaging in a Clinical Setting at 3 T. Investigative Radiology. 2012;47(12):677\u201382. doi: https:\/\/doi.org\/10.1097\/RLI.0b013e318267bc6f.","journal-title":"Investigative Radiology"},{"issue":"1","key":"5373_CR103","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jmri.26788","volume":"51","author":"T Barrett","year":"2020","unstructured":"Barrett T, Riemer F, McLean MA, Kaggie JD, Robb F, Warren AY, et al. Molecular imaging of the prostate: Comparing total sodium concentration quantification in prostate cancer and normal tissue using dedicated (13) C and (23) Na endorectal coils. J Magn Reson Imaging. 2020;51(1):90\u20137. doi: https:\/\/doi.org\/10.1002\/jmri.26788.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"5373_CR104","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/mrm.22196","volume":"63","author":"J Near","year":"2010","unstructured":"Near J, Bartha R. Quantitative sodium MRI of the mouse prostate. Magn Reson Med. 2010;63(3):822\u20137. doi: https:\/\/doi.org\/10.1002\/mrm.22196.","journal-title":"Magn Reson Med"},{"issue":"8","key":"5373_CR105","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/RLI.0000000000000470","volume":"53","author":"T Barrett","year":"2018","unstructured":"Barrett T, Riemer F, McLean MA, Kaggie J, Robb F, Tropp JS, et al. Quantification of Total and Intracellular Sodium Concentration in Primary Prostate Cancer and Adjacent Normal Prostate Tissue With Magnetic Resonance Imaging. Invest Radiol. 2018;53(8):450\u20136. doi: https:\/\/doi.org\/10.1097\/RLI.0000000000000470.","journal-title":"Invest Radiol"},{"issue":"5","key":"5373_CR106","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/jmri.26336","volume":"49","author":"NC Broeke","year":"2019","unstructured":"Broeke NC, Peterson J, Lee J, Martin PR, Farag A, Gomez JA, et al. Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology. J Magn Reson Imaging. 2019;49(5):1409\u201319. doi: https:\/\/doi.org\/10.1002\/jmri.26336.","journal-title":"J Magn Reson Imaging"},{"key":"5373_CR107","doi-asserted-by":"publisher","first-page":"106932","DOI":"10.1016\/j.jmr.2021.106932","volume":"326","author":"HM De Feyter","year":"2021","unstructured":"De Feyter HM, de Graaf RA. Deuterium metabolic imaging - Back to the future. J Magn Reson. 2021;326:106932. doi: https:\/\/doi.org\/10.1016\/j.jmr.2021.106932.","journal-title":"J Magn Reson"},{"issue":"1","key":"5373_CR108","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41747-024-00464-y","volume":"8","author":"F Pan","year":"2024","unstructured":"Pan F, Liu X, Wan J, Guo Y, Sun P, Zhang X, et al. Advances and prospects in deuterium metabolic imaging (DMI): a systematic review of in vivo studies. Eur Radiol Exp. 2024;8(1):65. doi: https:\/\/doi.org\/10.1186\/s41747-024-00464-y.","journal-title":"Eur Radiol Exp"},{"issue":"12","key":"5373_CR109","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-23-2552","volume":"84","author":"JCM Low","year":"2024","unstructured":"Low JCM, Cao J, Hesse F, Wright AJ, Tsyben A, Alshamleh I, et al. Deuterium Metabolic Imaging Differentiates Glioblastoma Metabolic Subtypes and Detects Early Response to Chemoradiotherapy. Cancer Res. 2024;84(12):1996\u20132008. doi: https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2552.","journal-title":"Cancer Res"},{"issue":"8","key":"5373_CR110","doi-asserted-by":"publisher","first-page":"eaat7314","DOI":"10.1126\/sciadv.aat7314","volume":"4","author":"HM De Feyter","year":"2018","unstructured":"De Feyter HM, Behar KL, Corbin ZA, Fulbright RK, Brown PB, McIntyre S, et al. Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo. Sci Adv. 2018;4(8):eaat7314. doi: https:\/\/doi.org\/10.1126\/sciadv.aat7314.","journal-title":"Sci Adv"},{"issue":"12","key":"5373_CR111","doi-asserted-by":"publisher","first-page":"e2014631118","DOI":"10.1073\/pnas.2014631118","volume":"118","author":"F Hesse","year":"2021","unstructured":"Hesse F, Somai V, Kreis F, Bulat F, Wright AJ, Brindle KM (2021) Monitoring tumor cell death in murine tumor models using deuterium magnetic resonance spectroscopy and spectroscopic imaging. Proc Natl Acad Sci USA 118(12):e2014631118. https:\/\/doi.org\/10.1073\/pnas.2014631118","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"5373_CR112","doi-asserted-by":"publisher","first-page":"e4569","DOI":"10.1002\/nbm.4569","volume":"34","author":"S Markovic","year":"2021","unstructured":"Markovic S, Roussel T, Agemy L, Sasson K, Preise D, Scherz A, et al. Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models. NMR Biomed. 2021;34(9):e4569. doi: https:\/\/doi.org\/10.1002\/nbm.4569.","journal-title":"NMR Biomed"},{"issue":"2","key":"5373_CR113","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/radiol.2019191242","volume":"294","author":"F Kreis","year":"2020","unstructured":"Kreis F, Wright AJ, Hesse F, Fala M, Hu DE, Brindle KM. Measuring Tumor Glycolytic Flux in Vivo by Using Fast Deuterium MRI. Radiology. 2020;294(2):289\u201396. doi: https:\/\/doi.org\/10.1148\/radiol.2019191242.","journal-title":"Radiology"},{"issue":"16","key":"5373_CR114","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.3390\/cancers13164034","volume":"13","author":"A Veltien","year":"2021","unstructured":"Veltien A, van Asten J, Ravichandran N, de Graaf RA, De Feyter HM, Oosterwijk E et al (2021) Simultaneous Recording of the Uptake and Conversion of Glucose and Choline in Tumors by Deuterium Metabolic Imaging. Cancers (Basel) 13(16):4034. https:\/\/doi.org\/10.3390\/cancers13164034","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5373_CR115","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/bem.22382","volume":"43","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao Y, Fang K, Ye JJ, Ruan YH, Yang XJ, et al. Proton\/Deuterium Magnetic Resonance Imaging of Rodents at 9.4T Using Birdcage Coils. Bioelectromagnetics. 2022;43(1):40\u20136. doi: https:\/\/doi.org\/10.1002\/bem.22382.","journal-title":"Bioelectromagnetics"},{"issue":"3","key":"5373_CR116","doi-asserted-by":"publisher","first-page":"e230101","DOI":"10.1148\/rycan.230101","volume":"6","author":"E Martinez Luque","year":"2024","unstructured":"Martinez Luque E, Liu Z, Sung D, Goldberg RM, Agarwal R, Bhattacharya A, et al. An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis. Radiol Imaging Cancer. 2024;6(3):e230101. doi: https:\/\/doi.org\/10.1148\/rycan.230101.","journal-title":"Radiol Imaging Cancer"},{"issue":"2","key":"5373_CR117","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/mrm.29012","volume":"87","author":"N Tayari","year":"2022","unstructured":"Tayari N, Wright AJ, Heerschap A. Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D (1) H MRSI without water-signal suppression. Magn Reson Med. 2022;87(2):561\u201373. doi: https:\/\/doi.org\/10.1002\/mrm.29012.","journal-title":"Magn Reson Med"},{"issue":"11","key":"5373_CR118","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/nbm.3373","volume":"28","author":"R Nagarajan","year":"2015","unstructured":"Nagarajan R, Iqbal Z, Burns B, Wilson NE, Sarma MK, Margolis DA, et al. Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy. NMR in Biomedicine. 2015;28(11):1366\u201373. doi: https:\/\/doi.org\/10.1002\/nbm.3373.","journal-title":"NMR in Biomedicine"},{"issue":"4","key":"5373_CR119","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/metabo13040577","volume":"13","author":"P Veeraiah","year":"2023","unstructured":"Veeraiah P, Jansen JFA (2023) Multinuclear Magnetic Resonance Spectroscopy at Ultra-High-Field: Assessing Human Cerebral Metabolism in Healthy and Diseased States. Metabolites 13(4):577. https:\/\/doi.org\/10.3390\/metabo13040577","journal-title":"Metabolites"},{"key":"5373_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnmrs.2018.06.001","volume":"109","author":"ME Ladd","year":"2018","unstructured":"Ladd ME, Bachert P, Meyerspeer M, Moser E, Nagel AM, Norris DG, et al. Pros and cons of ultra-high-field MRI\/MRS for human application. Prog Nucl Magn Reson Spectrosc. 2018;109:1\u201350. doi: https:\/\/doi.org\/10.1016\/j.pnmrs.2018.06.001.","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"issue":"12","key":"5373_CR121","doi-asserted-by":"publisher","first-page":"e5224","DOI":"10.1002\/nbm.5224","volume":"37","author":"A Frankini","year":"2024","unstructured":"Frankini A, Verma G, Seifert AC, Delman BN, Subramaniam V, Balchandani P, et al. Improvement of MRS at ultra-high field using a wireless RF array. NMR Biomed. 2024;37(12):e5224. doi: https:\/\/doi.org\/10.1002\/nbm.5224.","journal-title":"NMR Biomed"},{"issue":"12","key":"5373_CR122","doi-asserted-by":"publisher","first-page":"7955","DOI":"10.1002\/mp.16831","volume":"50","author":"J Wang","year":"2023","unstructured":"Wang J, Ji B, Lei Y, Liu T, Mao H, Yang XF. Denoising magnetic resonance spectroscopy (MRS) data using stacked autoencoder for improving signal-to-noise ratio and speed of MRS. Medical Physics. 2023;50(12):7955\u201366. doi: https:\/\/doi.org\/10.1002\/mp.16831.","journal-title":"Medical Physics"},{"issue":"5","key":"5373_CR123","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/mrm.27166","volume":"80","author":"SS Gurbani","year":"2018","unstructured":"Gurbani SS, Schreibmann E, Maudsley AA, Cordova JS, Soher BJ, Poptani H, et al. A convolutional neural network to filter artifacts in spectroscopic MRI. Magn Reson Med. 2018;80(5):1765\u201375. doi: https:\/\/doi.org\/10.1002\/mrm.27166.","journal-title":"Magn Reson Med"},{"issue":"5","key":"5373_CR124","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1002\/mrm.26948","volume":"79","author":"SP Kyathanahally","year":"2018","unstructured":"Kyathanahally SP, Mocioiu V, Pedrosa de Barros N, Slotboom J, Wright AJ, Julia-Sape M, et al. Quality of clinical brain tumor MR spectra judged by humans and machine learning tools. Magn Reson Med. 2018;79(5):2500\u201310. doi: https:\/\/doi.org\/10.1002\/mrm.26948.","journal-title":"Magn Reson Med"},{"issue":"6","key":"5373_CR125","doi-asserted-by":"publisher","first-page":"e4497","DOI":"10.1002\/nbm.4497","volume":"34","author":"B Ji","year":"2021","unstructured":"Ji B, Hosseini Z, Wang L, Zhou L, Tu X, Mao HA-O. Spectral Wavelet-feature Analysis and Classification Assisted Denoising for enhancing magnetic resonance spectroscopy. NMR Biomed. 2021;34(6):e4497.","journal-title":"NMR Biomed"},{"issue":"16","key":"5373_CR126","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.7150\/thno.61207","volume":"11","author":"SKB Spohn","year":"2021","unstructured":"Spohn SKB, Bettermann AS, Bamberg F, Benndorf M, Mix M, Nicolay NH, et al. Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies. Theranostics. 2021;11(16):8027\u201342. doi: https:\/\/doi.org\/10.7150\/thno.61207.","journal-title":"Theranostics"},{"issue":"1","key":"5373_CR127","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41392-023-01366-y","volume":"8","author":"JW Bai","year":"2023","unstructured":"Bai JW, Qiu SQ, Zhang GJ. Molecular and functional imaging in cancer-targeted therapy: current applications and future directions. Signal Transduct Target Ther. 2023;8(1):89. doi: https:\/\/doi.org\/10.1038\/s41392-023-01366-y.","journal-title":"Signal Transduct Target Ther"},{"key":"5373_CR128","doi-asserted-by":"publisher","first-page":"2234-943X","DOI":"10.3389\/fonc.2018.00516","volume":"8","author":"M Esmaeili","year":"2018","unstructured":"Esmaeili M, Tayari N, Scheenen T, Elschot M, Sandsmark E, Bertilsson H, et al. Simultaneous (18)F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer. Front Oncol. 2018;8(2234-943X (Print)):516. doi: https:\/\/doi.org\/10.3389\/fonc.2018.00516.","journal-title":"Front Oncol"},{"issue":"6","key":"5373_CR129","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/metabo12060488","volume":"12","author":"EP Resurreccion","year":"2022","unstructured":"Resurreccion EP, Fong KW (2022) The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. Metabolites 12(6):488. https:\/\/doi.org\/10.3390\/metabo12060488","journal-title":"Metabolites"},{"issue":"1","key":"5373_CR130","doi-asserted-by":"publisher","first-page":"16159","DOI":"10.1038\/s41598-017-16327-z","volume":"7","author":"NM Zacharias","year":"2017","unstructured":"Zacharias NM, McCullough C, Shanmugavelandy S, Lee J, Lee Y, Dutta P, et al. Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer. Sci Rep. 2017;7(1):16159. doi: https:\/\/doi.org\/10.1038\/s41598-017-16327-z.","journal-title":"Sci Rep"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05373-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05373-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05373-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:14:11Z","timestamp":1789452851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05373-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":130,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5373"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05373-1","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}